This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Freeman, J. W. Articles by Busch, H. Search for Related Content PubMed PubMed Citation Articles by Freeman, J. W. Articles by Busch, H.

Identification and Partial Characterization of a Nucleolar Antigen with a Molecular Weight of 145,000 Found in a Broad Range of Human Cancers¹

Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030

Previous studies in our laboratory have indicated the presence of nucleolar antigens in tumors which were not detected in normal tissues. Some of the polyclonal antisera produced in these studies were shown to identify a M_r 145,000 nucleolar antigen on immunoblots of tumor nucleoli but not in normal human liver nucleoli. A monoclonal antibody to a M_r 145,000 nucleolar protein (p145) was produced by immunization of mice with a nucleolar extract of HeLa cells which is enriched with this antigen. The monoclonal antibody showed bright nucleolar immunofluorescence localization in a broad range of human tumors including cancers of the gastrointestinal tract, genitourinary tract, lung, liver, muscle, cartilage, and blood. The p145 nucleolar antigen was not detected in most normal human tissues or in benign tumors, with only weak nucleolar staining observed in spermatogonia of the testes and in ductal regions of some hypertrophied prostates. Nucleolar antigen p145 was extracted from HeLa cell nucleoli by homogenization in a 0.01 M Tris buffer containing 0.2% deoxycholate. On sucrose density gradient centrifugation, the antigen remained sedimented with the nucleolar ribonucleoprotein fraction. Nucleolar antigen p145 was released from ribonucleoproteins following treatment with 4 M guanidinium hydrochloride or RNase. Peptide mapping of nucleolar antigen p145 showed that it was distinct from other known nucleolar antigens. Although it remains to be determined if the p145 antigen plays a role in cell transformation, maintenance of the malignant phenotype, or in cell division, it may have value as a tumor marker or as a therapeutic target.

¹ These studies were supported by Cancer Research Center Grant CA-10893, P1, awarded by National Cancer Institute, Department of Health and Human Services, USPHS; The DeBakey Medical Foundation; The Davidson Fund; The Pauline Sterne Wolff Memorial Foundation; H. Leland Kaplan Cancer Research Endowment; Linda and Ronny Finger Cancer Research Endowment Fund; and The William S. Farish Fund.

Received 1/27/86. Revised 4/ 1/86. Accepted 4/ 3/86.

This article has been cited by other articles:

				S. Kneissel, W. W. Franke, J. G. Gall, H. Heid, S. Reidenbach, M. Schnolzer, H. Spring, H. Zentgraf, and M. S. Schmidt-Zachmann A Novel Karyoskeletal Protein: Characterization of Protein NO145, the Major Component of Nucleolar Cortical Skeleton in Xenopus Oocytes Mol. Biol. Cell, December 1, 2001; 12(12): 3904 - 3918. [Abstract] [Full Text] [PDF]

				J. Amann, V. J. Kidd, and J. M. Lahti Characterization of Putative Human Homologues of the Yeast Chromosome Transmission Fidelity Gene, CHL1 J. Biol. Chem., February 7, 1997; 272(6): 3823 - 3832. [Abstract] [Full Text] [PDF]

				C. Pai, H. Chen, H. Sheu, and N. Yeh Cell-cycle-dependent alterations of a highly phosphorylated nucleolar protein p130 are associated with nucleologenesis J. Cell Sci., January 5, 1995; 108(5): 1911 - 1920. [Abstract] [PDF]